Trial Profile
A Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Prior to First Dose of VIVITROL
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Mar 2019
Price :
$35
*
At a glance
- Drugs Naltrexone (Primary) ; Naltrexone (Primary) ; Buprenorphine
- Indications Opioid-related disorders
- Focus Registrational; Therapeutic Use
- Sponsors Alkermes plc
- 13 Feb 2017 Status changed from active, no longer recruiting to completed.
- 21 Dec 2016 Status changed from recruiting to active, no longer recruiting.
- 12 Nov 2015 Planned primary completion date changed from 1 Oct 2016 to 1 Dec 2016 as reported by ClinicalTrials.gov record.